Bayesian Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,269	Closed	-$253K	–	840
2024 Q3	$253K	Buy	+2,269	New	+$249K	0.03%	516
2023 Q4	–	Sell	-4,858	Closed	-$629K	–	886
2023 Q3	$629K	Buy	4,858 +3,000	+161%	+$400K	0.07%	320
2023 Q2	$230K	Sell	1,858 -8,029	-81%	-$1.08M	0.02%	604
2023 Q1	$1.45M	Buy	9,887 +699	+8%	+$103K	0.18%	167
2022 Q4	$1.46M	Buy	9,188 +3,600	+64%	+$528K	0.21%	105
2022 Q3	$745K	Buy	+5,588	New	+$850K	0.15%	186
2021 Q4	–	Sell	-4,889	Closed	-$637K	–	452
2021 Q3	$637K	Sell	4,889 -3,311	-40%	-$500K	0.18%	149
2021 Q2	$1.46M	Sell	8,200 -1,111	-12%	-$192K	0.38%	72
2021 Q1	$1.53M	Buy	+9,311	New	+$1.53M	0.35%	71
2019 Q3	–	Sell	-16,007	Closed	-$2.28M	–	599
2019 Q2	$2.28M	Buy	+16,007	New	+$2.15M	0.47%	53
2018 Q3	–	Sell	-1,300	Closed	-$224K	–	712
2018 Q2	$224K	Buy	+1,300	New	+$212K	0.05%	491
2018 Q1	–	Sell	-1,862	Closed	-$251K	–	708
2017 Q4	$251K	Buy	+1,862	New	+$258K	0.05%	454
2017 Q1	–	Sell	-7,600	Closed	-$829K	–	553
2016 Q4	$829K	Buy	+7,600	New	+$847K	0.21%	181
2016 Q3	–	Sell	-1,700	Closed	-$240K	–	430
2016 Q2	$240K	Buy	+1,700	New	+$251K	0.14%	275